4772
1000+
193
8
1083
Cat. No. | Product Name | ||
---|---|---|---|
L7000 | 活性脂质化合物库 | 385 compounds | |
385 种生物活性小分子化合物,用于高通量、高内涵筛选; | |||
L2620 | 神经退行性疾病化合物库 | 2154 compounds | |
2154 种与神经退行性疾病相关的化合物,可用于高通量和高内涵筛选; | |||
L5700 | 精选片段库 | 246 compounds | |
246 个片段小分子的独特集合,可用于基于片段的筛选和药物发现(FBDD); | |||
L3980 | DNA损伤/修复库Plus | 667 compounds | |
667 种 DNA 损伤/修复靶向、结构新颖的化合物; | |||
L1020 | EMA 上市药物库 | 657 compounds | |
657个EMA批准药物的独特集合,可用于高通量筛选和高内涵筛选 | |||
L1510 | 核受体化合物库 | 531 compounds | |
531 个核受体作用化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L1400 | MAPK 抑制剂库 | 365 compounds | |
365 种与MAPK 信号通路相关的生物活性小分子化合物的特有集合,可用于高通量筛选和高内涵筛选; | |||
L2110 | 抗癌上市药物库 | 1779 compounds | |
1779 个具有抗癌活性小分子的独特集合,所有化合物都经过了严格的临床前研究和临床试验,由FDA、EMA 或NMPA 批准上市,可用于高通量、高内涵筛选。 | |||
L2191 | 抗乳腺癌化合物库 | 1939 compounds | |
1939 种与乳腺癌相关的化合物,可以用于抗乳腺癌药物研发和药理研究; | |||
L2550 | 谷氨酰胺代谢化合物库 | 565 compounds | |
565 种谷氨酰胺代谢相关的分子,可以用于高通量和高内涵筛选; | |||
L2200 | 酪氨酸激酶分子库 | 1016 compounds | |
1016 种酪氨酸激酶抑制剂的独特集合,可用于高通量筛选和高内涵筛选; | |||
L3100 | 造血毒性小分子库 | 101 compounds | |
101 种生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L3800 | NF-κB 通路分子库 | 729 compounds | |
729 个 NF-κB 信号通路相关的小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L4300 | Wnt/Hedgehog/Notch 通路化合物库 | 237 compounds | |
237 个Wnt & Hedgehog & Notch 靶点相关的生物活性小分子化合物的特有集合,用于相关通路的研究及药物的筛选,可用于高通量、高内涵筛选。 | |||
L4100 | TGF-β/Smad靶点化合物库 | 184 compounds | |
184 个 TGF-β/Smad 靶点相关的小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L5900 | 血脑屏障通透化合物库 | 509 compounds | |
509 个 CNS-Penetrant 生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L3500 | 组蛋白修饰化合物库 | 469 compounds | |
469 个组蛋白修饰相关的小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L4510 | 抗寄生虫库 | 419 compounds | |
419 种具有抗寄生虫活性的小分子化合物; | |||
L6750 | 活血化瘀中药单体库 | 580 compounds | |
580种来源于常见活血化瘀中药的单体化合物,是药物开发、药理研究等领域的有效工具。 | |||
L7500 | 凝血与抗凝化合物库 | 144 compounds | |
144 个化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L7300 | 钾通道分子库 | 152 compounds | |
152 种钾通道相关化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L7700 | 神经再生化合物库 | 524 compounds | |
524 种神经再生相关化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L7900 | 成骨分子库 | 317 compounds | |
317 种成骨相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L8800 | 药物片段库 | 1119 compounds | |
1119 种药物片段分子,是FBDD 方法新药筛选的有力工具; | |||
L8110 | 细胞重编程化合物库 | 1813 compounds | |
1813 种重编程信号通路相关的生物活性小分子化合物的特有集合,可用于高通量、高内涵筛选 | |||
L6730 | 抗病毒中药单体化合物库 | 268 compounds | |
268 种具有抗病毒活性的中药单体集合,是药物开发、药理研究的有效工具; | |||
L2193 | 抗肝癌化合物库 | 1787 compounds | |
1787 种与肝癌相关的化合物,可以用于抗肝癌药物研发和药理研究; | |||
L6740 | 抗结直肠癌中药单体化合物库 | 382 compounds | |
382 种抗结直肠癌相关的中药单体集合,是药物开发、药理研究的有效工具; | |||
L2196 | 抗卵巢癌化合物库 | 1867 compounds | |
1867 种与卵巢癌相关的化合物,可以用于抗卵巢癌药物研发和药理研究 | |||
L2194 | 抗结直肠癌化合物库 | 1545 compounds | |
1545 种与结直肠癌相关的化合物,可以用于高通量和高内涵筛选; | |||
L9210 | 儿童药物库 | 972 compounds | |
972 种儿童药物的独特集合,可用于高通量筛选和高内涵筛选 | |||
L2521 | 糖酵解化合物库 | 555 compounds | |
555 种糖酵解相关的活性化合物,可用于高通量和高内涵筛选 | |||
L3200 | 自噬库 | 1248 compounds | |
1248 种细胞自噬相关的生物活性小分子化合物的特有集合,用于自噬相关的研究,用于高通量、高内涵筛选; | |||
L6900 | 稀有天然产物库 | 693 compounds | |
693 种稀有天然产物的集合,可以用于高通量和高内涵筛选; | |||
L9200 | 药物功能重定位化合物库 | 4541 compounds | |
4541 种全球上市药物和临床药物的独特集合,可用于高通量筛选和高内涵筛选,是老药新用、新的药物靶点筛选和细胞诱导的有效工具。 | |||
L9850 | 口服活性化合物库 | 2427 compounds | |
2427 种口服活性化合物独特集合,可用于高通量筛选和高内涵筛选 | |||
L3900 | DNA 损伤和修复分子库 | 910 compounds | |
910 个与 DNA 损伤和修复紧密相关的化合物集合,是高通量筛选,高内涵筛选的良好载体; | |||
L3400 | 临床期小分子药物库 | 3404 compounds | |
3404 个临床期化合物集合,可用于高通量筛选和高内涵筛选; | |||
L6120 | 黄酮类天然产物库 | 514 compounds | |
514 种黄酮类天然产物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L1100 | 蛋白酶抑制剂库 | 343 compounds | |
343 种已知的小分子蛋白酶抑制剂的特有集合,可用于高通量筛选和高内涵筛选; | |||
L2130 | 抗癌细胞代谢库 | 1268 compounds | |
1268 种癌细胞代谢相关的生物活性小分子化合物的特有集合,用于肿瘤相关的研究以及抗肿瘤药物的筛选,用于高通量、高内涵筛选; | |||
L5200 | 抗代谢疾病化合物库 | 1544 compounds | |
1544 个代谢疾病相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L9400 | PPI抑制剂库 | 485 compounds | |
485 种已知活性的 PPI 相关的抑制剂,可用于高通量、高内涵筛选; | |||
L6130 | 萜类天然产物库 | 516 compounds | |
516 种萜类天然产物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L7860 | Mini片段亲电杂环化合物库 | 369 compounds | |
高溶解度共价杂环片段库中的 369 个化合物 | |||
L1120 | AMPK靶向分子库 | 80 compounds | |
80 个靶向AMPK 的分子集合,可用于高通量和高内涵筛选; | |||
L7600 | 趋化因子抑制剂库 | 59 compounds | |
59 种趋化因子或其受体抑制剂的独特集合,可用于高通量筛选和高内涵筛选; | |||
L7840 | 高溶解性卤化片段化合物库 | 796 compounds | |
高溶解性卤化片段库包含796 个卤化片段化合物。 | |||
L7810 | 高溶解性多官能团片段化合物库 | 1159 compounds | |
高溶解性多官能团片段库包含1159 种片段分子 | |||
L6001 | Mini真菌代谢天然产物筛选库 | Inquiry | |
L4700 | 免疫/炎症分子化合物库 | 4720 compounds | |
4720 种具有抗炎症活性的化合物的特有集合,可用于高通量筛选和高内涵筛选; | |||
L2120 | 抗癌临床化合物库 | 2545 compounds | |
2545 个具有抗癌活性小分子的独特集合,可用于高通量高内涵筛选。 | |||
L2150 | 抗癌药物库 | 3080 compounds | |
3080 个具有抗癌活性小分子的独特集合,生物活性已经临床前实验证实,可用于高通量、高内涵筛选; | |||
L2000 | 抑制剂库 | 8328 compounds | |
8328 个小分子抑制剂的独特集合,主要用于细胞信号研究、新药筛选、高通量筛选和高内涵筛选; | |||
L3700 | JAK-STAT 化合物库 | 252 compounds | |
252 个 JAK/STAT 靶点相关的小分子化合物的独特集合,用于高通量、高内涵筛选; | |||
L2700 | 肾上腺素能受体化合物库 | 193 compounds | |
193 种特异靶向肾上腺素受体的生物活性小分子化合物的集合,是相关疾病药物筛选的有效工具; | |||
L5510 | 肝脏毒性化合物库 | 1001 compounds | |
1001 个肝脏毒性化合物的特有集合,可用于高通量、高内涵筛选,是毒理学研究的良好工具; | |||
L5100 | 含氟化合物库 | 574 compounds | |
574 个含氟化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L4600 | 植物来源化合物库 | 3048 compounds | |
3048 个植物来源天然产物的独特集合,来自277类植物的精心之选; | |||
L4800 | 血管生成库 | 1353 compounds | |
1353 个高潜力的抑制或促进血管生成的小分子集合,可用于药物靶点开发、血管生成机理研究的高通量筛选,高内涵筛选; | |||
L5500 | 毒性化合物库 | 262 compounds | |
262 个细胞毒性化合物的特有集合,可用于高通量、高内涵筛选。 | |||
L7110 | 抗高血压化合物库 | 678 compounds | |
678 种高血压相关的小分子,用于高通量和高内涵筛选; | |||
L6600 | 胃肠炎天然产物库 | 219 compounds | |
219 种胃肠炎相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L8500 | HIF-1化合物库 | 1336 compounds | |
1336 个HIF-1相关小分子的独特集合,可用于缺血性疾病、癌症等相关领域的药物开发和药理研究; | |||
L7850 | 高溶解性3D结构多样性片段化合物库 | 1079 compounds | |
高溶解性3D 结构多样性片段库包含1079 个化合物。 | |||
L7800 | 高溶解性片段库 | 2728 compounds | |
2728 种片段分子合集,数量适中,是 FBDD 方法新药筛选的有力工具。 | |||
L9100 | 磷酸酶抑制剂化合物库 | 79 compounds | |
79 种已知活性的磷酸酶抑制剂的集合,可用于化合物筛选、化学基因组学、药理分析等方面; | |||
L6620 | 抗寄生虫天然产物库 | 253 compounds | |
253 个抗寄生虫相关的天然产物集合,是药物开发、药理研究的有效工具; | |||
L9001 | 食品添加剂化合物库 | 425 compounds | |
425种食品添加剂的集合 | |||
L4210 | NMPA中国上市药物库 | 1270 compounds | |
1270 个 NMPA 中国上市药物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L2010 | 高选择性抑制剂库 | 575 compounds | |
575种具有高选择性的抑制剂集合 | |||
L1000 | 上市药物库 | 2808 compounds | |
2808 个上市药物化合物集合,可用于高通量筛选和高内涵筛选; | |||
L8100 | 细胞周期化合物库 | 677 compounds | |
677 种细胞周期相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L6160 | Ro5类药天然产物库 | 2703 compounds | |
2703 种符合 RO5原则的天然产物单体集合,可以用于高通量和高内涵筛选; | |||
L1520 | 膜蛋白靶向化合物库 | 4175 compounds | |
L6610 | 抗感染天然产物库 | 1060 compounds | |
1060 个抗感染相关的天然产物集合,是药物开发、药理研究的有效工具; | |||
L1010 | FDA上市及药典收录分子库 | 3158 compounds | |
3158 个上市及药典分子集合,可用于高通量筛选和高内涵筛选; | |||
L1600 | 激酶抑制剂库 | 2720 compounds | |
2720 种激酶抑制剂/调节剂的独特集合,用于特定靶向激酶,可用于高通量筛选和高内涵筛选; | |||
L2510 | 脂代谢化合物库 | 492 compounds | |
492 个脂代谢相关的化合物集合,可用于高通量和高内涵筛选; | |||
L6100 | 天然多酚类化合物库 | 635 compounds | |
635 个天然多酚化合物的独特集合,可用于高通量、高内涵筛选; | |||
L6810 | 中药单体化合物库 | 2755 compounds | |
2755 种中药来源的单体化合物,是药物开发、药理研究等领域的有力工具; | |||
L4150 | 新颖已知活性精选库 | 989 compounds | |
989 种百里挑一的活性化合物; | |||
L4660 | 神经疾病库Plus | 1246 compounds | |
1246 种神经系统相关、结构新颖的化合物; | |||
L1580 | GPCR库Plus | 338 compounds | |
338 种GPCR 靶向、结构新颖的化合物; | |||
L6020 | 天然产物单体化合物库 | 16627 compounds | |
16627 种精选天然产物集合,结构多样,遍布多种动植物与微生物; | |||
L6030 | 天然产物衍生物虚筛化合物库 | 163000 compounds | |
16.3万种天然产物衍生物,并且在持续增加中; | |||
L1300 | PI3K/Akt/mTOR 化合物库 | 420 compounds | |
420 种与PI3K/Akt/mTOR 相关的生物活性小分子化合物的特有集合,用于PI3K/Akt/mTOR 相关研究以及高通量、高内涵筛选; | |||
L2152 | 靶向治疗药物库 | 119 compounds | |
119 个肿瘤靶向治疗药物,可以用于高通量和高内涵筛选; | |||
L2151 | 化疗药物库 | 48 compounds | |
48 个肿瘤化疗药物,可以用于高通量和高内涵筛选; | |||
L2520 | 糖代谢化合物库 | 702 compounds | |
702 种糖代谢相关的化合物,可用于高通量和高内涵筛选; | |||
L2400 | 内分泌激素分子库 | 784 compounds | |
784 种与内分泌系统相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L2530 | 小鼠代谢化合物库 | 218 compounds | |
218 种小鼠代谢化合物的集合,可用于高通量筛选和高内涵筛选; | |||
L3510 | 甲基化化合物库 | 128 compounds | |
128 种甲基化相关的化合物,可以用于高通量和高内涵筛选; | |||
L2800 | 5-羟色胺分子库 | 268 compounds | |
268 种生物活性小分子化合物,用于高通量、高内涵筛选; | |||
L2910 | 抗氧化化合物库 | 1314 compounds | |
氧化应激(Oxidative Stress,OS)是指体内氧化与抗氧化作用失衡的一种状态。氧化应激导致活性氧(ROS)大量积累,氧化程度超出抗氧化物的清除能力,从而引起氧化损伤,氧化应激损伤是许多疾病发生的基础,不同程度的氧化应激造成的细胞效应与心脑血管疾病、神经退行性病变、炎症和肿瘤密切相关。抗氧化剂是一类能够对抗氧化应激,降低氧化损伤的一类化合物。 TargetMol 抗氧化化合物库是1314 种对氧化应激具有抑制作用的小分子特有集合,是研究氧化应激的有用工具,可以用于高通量筛选和高内涵筛选。 | |||
L4500 | 抗真菌库 | 252 compounds | |
252 个抗真菌活性化合物的独特集合,包含作用于真菌相关靶点的化合物和临床中用于真菌类疾病的药物,是相关疾病药物筛选的有效工具。 | |||
L3410 | 临床前化合物库 | 701 compounds | |
701 种临床前小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L5800 | 药物代谢杂质库 | 197 compounds | |
197 种药物异构体/代谢产物的特有集合,可用于高通量、高内涵筛选; | |||
L6500 | 微生物天然产物库 | 550 compounds | |
550 种微生物来源的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L6230 | 苗药化合物库 | 534 compounds | |
534种苗族特色药材的天然产物分子,可用于高通量和高内涵筛选 | |||
L7820 | 高溶解性微型片段化合物库 | 1081 compounds | |
高溶解性微型片段化合物库由 1081 个低分子量片段组成。 | |||
L8400 | 血液病分子库 | 514 compounds | |
514 种造血系统疾病相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L8700 | 铁死亡化合物库 | 779 compounds | |
779 种与铁死亡通路相关的化合物,可用于高通量和高内涵筛选; | |||
L8300 | 染色质修饰分子库 | 250 compounds | |
250 种染色质化学修饰相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L9830 | 抗帕金森病化合物库 | 857 compounds | |
857 种帕金森病相关的化合物集合,可用于高通量和高内涵筛选; | |||
L9820 | β-内酰胺类化合物库 | 97 compounds | |
97 种β-内酰胺类化合物的集合,可以用于高通量和高内涵筛选; | |||
L9840 | 抗阿尔茨海默症化合物库 | 986 compounds | |
986 种阿尔茨海默症相关的化合物集合,可用于高通量和高内涵筛选; | |||
L9610 | 环肽库 | 55 compounds | |
55 种环肽分子,可用于高通量和高内涵筛选; | |||
L7870 | 可溶性羧酸片段化合物库 | 1806 compounds | |
可溶性羧酸片段库包含 1806 个化合物 | |||
L4710 | 非甾体类抗炎化合物库 | 530 compounds | |
530 种非甾体类的抗炎相关化合物,可用于高通量和高内涵筛选; | |||
L6210 | 藏药化合物库 | 747 compounds | |
747 种藏药来源的天然产物分子集合,可以用于高通量和高内涵筛选; | |||
L2610 | 神经递质受体化合物库 | 1513 compounds | |
1513 种与神经递质受体相关的化合物,用于高通量、高内涵筛选; | |||
L6010 | 天然产物库 | 3840 compounds | |
3840 种天然产物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L5400 | 抗心血管疾病化合物库 | 1408 compounds | |
1408 种心血管疾病相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L6400 | 海洋天然产物库 | 144 compounds | |
144 种海洋来源的单体化合物,是药物开发、药理研究等领域的有力工具; | |||
L1900 | 抗糖尿病库 | 683 compounds | |
683 种生物活性小分子化合物; | |||
L2570 | 人代谢物化合物库 | 4454 compounds | |
4454 种人代谢物的独特集合,用于高通量、高内涵筛选; | |||
L2501 | 人内源代谢化合物库 Plus | 1283 compounds | |
1283种内源性生物活性化合物的独特集合,用于高通量、高内涵筛选。 | |||
L2300 | 离子通道库 | 931 compounds | |
931 种与离子通道相关的生物活性小分子化合物的特有集合,用于离子通道相关的疾病和药物研究,可用于高通量筛选和高内涵筛选; | |||
L1500 | GPCR靶点分子库 | 1940 compounds | |
1940 种与 G 蛋白及其耦联受体相关的生物活性小分子化合物,所有小分子都具有良好的生物和药理活性,部分是 FDA 批准的上市药物; | |||
DF4500 | 多样性核心库Part1 | 50000 compounds | |
绝大部分分子量<500,主要集中于250-450之间,方便后续的改造优化; | |||
L9700 | 内质网应激化合物库 | 193 compounds | |
193 个内质网应激相关的化合物集合,可用于高通量和高内涵筛选; | |||
L1110 | 微管靶向化合物库 | 142 compounds | |
142 种靶向微管的分子集合,用于高通量筛选和高内涵筛选; | |||
L1310 | 细胞骨架化合物库 | 759 compounds | |
759 种细胞骨架相关的化合物,可以用于高通量和高内涵筛选; | |||
L1610 | FDA 上市激酶抑制剂库 | 263 compounds | |
263种靶向激酶的上市药物集合,用于特定靶向激酶,可用于高通量筛选和高内涵筛选; | |||
L4020 | NO PAINS 化合物库 | 9384 compounds | |
TargetMol NO PAINS 化合物库包含 9384 个剔除了PAINS 的小分子活性化合物,可用于新药研发,信号通路研究,老药新用等研究。 | |||
L1800 | 抗感染化合物库 | 2938 compounds | |
2938 种具有抗感染活性的化合物的特有集合,包括抗细菌、抗真菌、抗巨细胞病毒、抗HIV、抗SARS、抗流感等活性; | |||
L2140 | 癌细胞分化化合物库 | 406 compounds | |
406 个诱导肿瘤细胞分化化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L2192 | 抗胰腺癌化合物库 | 2238 compounds | |
2238 种与胰腺癌相关的化合物,可以用于高通量和高内涵筛选; | |||
L2900 | 氧化还原化合物库 | 1264 compounds | |
1264 个活性化合物,已经验证具有一定的抗氧化活性,包括 ROS 清除剂、iNOS、eNOS、及抗氧化的天然产物,是研究疾病机理以及药物研究的优良载体 | |||
L3600 | 细胞因子抑制剂库 | 604 compounds | |
604 个与细胞因子紧密相关的化合物集合,是高通量、高内涵筛选的良好载体; | |||
L4900 | 心血管毒性化合物库 | 131 compounds | |
131 种心血管毒性化合物的独特集合,可用于毒理学研究; | |||
L6700 | 抗癌天然产物库 | 1772 compounds | |
1772 种已知活性天然产物的独特集合,是肿瘤药物开发、抗癌先导化合物筛选等领域的有力工具,可用于HTS 和HCS。 | |||
L6300 | 药食同源库 | 1290 compounds | |
1290 个药食同源化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L6150 | 天然产物共价化合物库 | 583 compounds | |
提供产品的生物学信息和药物学信息,为筛选提供理论方向和研究基础; | |||
L6800 | 中国药典收录天然产物库 | 2051 compounds | |
2051 种中国药典收录的天然产物,是药物开发、药理研究等领域的有力工具; | |||
L6710 | 中药抗炎分子库 | 1246 compounds | |
1246 种具有抗炎活性或靶向炎症相关靶点的中药单体集合,是药物开发、药理研究的有效工具; | |||
L7400 | 钠通道分子库 | 118 compounds | |
118 种钠通道相关化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L7200 | 钙通道分子库 | 140 compounds | |
140 种钙通道相关化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L8200 | 抗衰老化合物库 | 3279 compounds | |
3279 个抗衰老化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L9410 | 共价抑制剂库 | 1920 compounds | |
1920 种小分子的独特集合,包含已发现的共价抑制剂以及包含某些共价反应基团常见弹头的分子,如氯乙酰基,2-氯丙酰基,丙烯酰基,1-丙-2-炔基,1-丁-2-炔基,酮羰基,二硫键等,可以用于共价抑制剂药物研发; | |||
L9300 | 大环化合物库 | 210 compounds | |
210 种活性已知的大环化合物,用于高通量、高内涵筛选; | |||
L9000 | 细胞凋亡化合物库 | 1760 compounds | |
1760 种与凋亡相关的生物活性小分子化合物的特有集合,多用于研究肿瘤发生发展机制和抗癌药物筛选等。可用于高通量筛选和高内涵筛选; | |||
L2630 | 神经元分化化合物库 | 672 compounds | |
672 种与神经元分化相关的化合物,可以用于神经系统疾病药物研发 | |||
L9230 | ReFRAME 相关化合物库 | 3210 compounds | |
3210 化合物的独特集合,可用于高通量筛选和高内涵筛选 | |||
L9900 | 药用辅料化合物库 | 182 compounds | |
182 种 FDA 批准药品中的非活性成分集合 | |||
L2195 | 抗前列腺癌化合物库 | 2070 compounds | |
2070 种与前列腺癌相关的化合物,可以用于高通量和高内涵筛选 | |||
NY1000 | 天然产物衍生物库 | 4000 compounds | |
22个天然产物骨架,3745个天然产物衍生物; | |||
L6110 | 生物碱类天然产物库 | 464 compounds | |
464 种生物碱类天然产物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L4520 | 抗菌活性库 | 904 compounds | |
904 种具有抗菌活性的化合物,是抗菌药物研发的有力工具; | |||
L8000 | 干细胞分化化合物库 | 1197 compounds | |
1197 种干细胞分化信号通路相关的生物活性小分子化合物的特有集合,可用于高通量、高内涵筛选; | |||
L4400 | 抗生素库 | 692 compounds | |
692 个具有抗菌活性化合物的独特集合,是医药研究的优良工具库和药物筛选的有效载体; | |||
L5610 | Golden骨架库 | 10000 compounds | |
多样性好,从160万个小分子中挑选而出,10000 个化合物,5000种骨架结构; | |||
L5300 | 线粒体靶向库 | 812 compounds | |
812 种具有潜在或确定线粒体靶向活性的化合物,以促进针对线粒体的药物研究; | |||
L4200 | FDA 上市药物库 | 1729 compounds | |
1729 个FDA 批准药物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L7100 | 抗肥胖化合物库 | 2247 compounds | |
2247 个抗肥胖化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L2500 | 人内源代谢化合物库 | 499 compounds | |
499 种内源性生物活性化合物的独特集合,用于高通量、高内涵筛选; | |||
L2540 | 肠道微生物代谢化合物库 | 607 compounds | |
607 种肠道微生物代谢物的集合,可以用于高通量和高内涵筛选; | |||
L6000 | 高通量筛选天然产物库 | 4533 compounds | |
4533 种天然产物的独特集合,是药物开发、药理研究、干细胞分化、指纹图谱研究、质量研究等领域的有力工具,可用于HTS 和HCS; | |||
L2100 | 抗癌化合物库 | 7234 compounds | |
7234 种肿瘤相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L4000 | 经典已知活性库 | 14439 compounds | |
14439 个已知活性化合物的集合,可用于高通量筛选、高内涵筛选、细胞诱导和靶点确认; | |||
DO1200 | 药物靶点库 | 53200 compounds | |
数量多,含53200种小分子化合物,是高通量筛选的有力工具; | |||
VM1400 | 多样性核心库Part2 | 25920 compounds | |
分子量<500,主要集中于250-450之间,方便后续的改造优化; | |||
D7800 | 新颖已知活性库 | 8118 compounds | |
提高成功率:新增8118种已知活性化合物,提高实验成功率。 | |||
L7830 | 高溶解性片段药效团化合物库 | 985 compounds | |
高溶解性片段药效团库包含985 个片段小分子。 | |||
L2180 | 抗肿瘤库Plus | 1468 compounds | |
1468 种抗肿瘤相关、结构新颖的化合物; | |||
L1380 | 转录因子库 | 695 compounds | |
695 种转录因子靶向、结构新颖的化合物; | |||
L1710 | 抗COVID-19化合物库 | 1133 compounds | |
1133 种对SARS-CoV-2有抑制作用或潜在抑制作用的化合物集合,可用于高通量和高内涵筛选; | |||
L3300 | 组胺&褪黑色素化合物库 | 153 compounds | |
153 种生物活性小分子化合物,用于高通量、高内涵筛选; | |||
L9411 | 半胱氨酸共价化合物库 | 70 compounds | |
半胱氨酸共价库包含 70 个化合物。 | |||
L9420 | 外泌体相关化合物库 | 76 compounds | |
76 种外泌体相关的化合物,可以用于高通量和高内涵筛选; | |||
L8600 | 泛素化化合物库 | 210 compounds | |
210 种泛素化相关的小分子,用于高通量和高内涵筛选; | |||
L8710 | 铜死亡化合物库 | 400 compounds | |
TargetMol 铜死亡化合物库集合了 400 种与铜死亡相关的化合物,可以用于铜死亡机制及相关疾病研究 | |||
L9500 | 表型筛选靶点鉴定库 | 1796 compounds | |
1796 种靶点明确的已知活性化合物,适合表型筛选; | |||
L9860 | 抗抑郁症化合物库 | 1163 compounds | |
1163 种与抑郁症相关的化合物,可以用于高通量和高内涵筛选 | |||
L6820 | 烟草单体化合物库 | 747 compounds | |
747种烟草单体化合物的独特集合,可用于高通量筛选和高内涵筛选 | |||
L6200 | 瑶药化合物库 | 221 compounds | |
221 种瑶药来源的天然产物分子集合,可以用于高通量和高内涵筛选; | |||
L2560 | 代谢化合物库 | 2320 compounds | |
2320 种代谢途径相关的化合物,可用于高通量和高内涵筛选。 | |||
L9810 | 抗纤维化化合物库 | 1180 compounds | |
1180 种潜在的抗纤维化分子,是研究纤维化的有效工具,可以用于高通量筛选和高内涵筛选; | |||
L5600 | Mini骨架库 | 5000 compounds | |
多样性好,从一百多万个小分子中挑选而出,5000 个化合物代表5000 种骨架结构; | |||
L2190 | 抗肺癌化合物库 | 1702 compounds | |
1702 种与肺癌相关的化合物,可以用于抗肺癌药物研发和药理研究; | |||
L1200 | 表观遗传库 | 953 compounds | |
953 种表观遗传学研究相关的生物活性小分子的特有集合,用于表观遗传学研究及其相关的检测和高通量、高内涵筛选; | |||
L1720 | 核苷类化合物库 | 334 compounds | |
334 种核苷类化合物,包括核苷酸、核苷酸类似物及衍生物等,适用于抗病毒、抗肿瘤、抗真菌、抗抑郁等药物的研发; | |||
L6220 | 蒙药化合物库 | 950 compounds | |
950 种蒙药来源的天然产物分子集合,可以用于高通量和高内涵筛选; | |||
L8720 | 细胞焦亡化合物库 | 1066 compounds | |
1066 种细胞焦亡相关的化合物,可以用于细胞焦亡相关研究。 | |||
L2170 | 肿瘤免疫治疗小分子化合物库 | 449 compounds | |
449 种靶向肿瘤免疫治疗靶点的小分子,可用于高通量和高内涵筛选,是研究肿瘤免疫治疗的有力工具; | |||
L9600 | 多肽分子库 | 791 compounds | |
791 种多肽类分子,可用于多肽药物开发及信号转导通路和作用机制研究; | |||
L6720 | 抗COVID-19中药单体库 | 1147 compounds | |
根据抗新冠肺炎疫情过程中应用于临床治疗的中药方剂,收集了1147 种相关中药来源的单体化合物,可用于高通量和高内涵筛选,是抗新冠病毒药物研发的良好工具; | |||
L2600 | 神经信号分子库 | 2540 compounds | |
2540 种CNS 相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L1700 | 抗病毒库 | 1040 compounds | |
1040 种具有抗病毒活性的化合物的特有集合,是筛选新型抗病毒药的有效工具;可用于高通量筛选和高内涵筛选; | |||
L6140 | 糖类及苷类化合物库 | 362 compounds | |
362 种糖类或苷类的化合物,可用于高通量筛选和高内涵筛选; | |||
L2160 | 抗癌活性化合物库 | 3188 compounds | |
3188 种具有抗肿瘤活性的化合物的特有集合,用于高通量、高内涵筛选; | |||
L4010 | 已知活性化合物库 | 22555 compounds | |
22555 个已知活性化合物的集合,可用于高通量筛选、高内涵筛选、细胞诱导和靶点确认; |
Cat. No. | Product Name | Form | Specificity Of Inhibition |
---|---|---|---|
CL0124 |
AMPAR antagonist/activator kit
AMPAR antagonist/activator kit |
||
CL0093 |
PARP inhibitor kit
PARP inhibitor kit |
||
CL0050 |
Antiparasitic compound kit
Antiparasitic compound kit |
||
C0113 |
Magrose Beads Heparin
肝素磁珠 |
||
CL0104 |
NMDAR agonist/antagonist kit
NMDAR agonist/antagonist kit |
||
CL0099 |
RAR/RXR agonist kit
RAR/RXR agonist kit |
||
CL0076 |
PPAR inhibitor/activator kit
PPAR inhibitor/activator kit |
||
CL0138 |
Carbonic Anhydrase inhibitor kit
Carbonic Anhydrase inhibitor kit |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1881 |
AR-A014418
AR 0133418,GSK-3beta Inhibitor VIII,AR 014418,GSK 3β inhibitor VIII |
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
AR-A014418 (GSK 3β inhibitor VIII) 是选择性的,ATP 竞争性的 GSK3β抑制剂 ,其 IC50=104 nM,Ki=38 nM。 | |||
T14315 |
AR-9281
APAU |
Epoxide Hydrolase | Metabolism |
AR-9281 (APAU) 是选择性的可溶性环氧化物水解酶抑制剂,可用于研究高血压和 2 型糖尿病。 | |||
T21646L |
AR-M 1896 Acetate
AR-M 1896 Acetate (367518-31-8 Free base) |
Neuropeptide Y Receptor | GPCR/G Protein; Neuroscience |
AR-M 1896 Acetate 是 GalR2 的选择性激动剂。 | |||
T14316 |
AR-C155858
|
Monocarboxylate transporter | Membrane transporter/Ion channel |
AR-C155858 是单羧酸转运蛋白 MCT1 和 MCT2 的抑制剂,Ki 分别为2.3和 10 nM。 | |||
T8329 |
AR 231453
|
GPR | Endocrinology/Hormones; GPCR/G Protein |
AR 231453 是一种口服具有活性的、特异性的 GPR119激动剂。它能够刺激细胞增殖,改善胰岛 β 细胞的功能。 | |||
T26647 |
AR420626
AR 420626,AR-420626 |
Others | Others |
AR420626 是一种选择性脂肪酸 3 受体 (FA3R) 激动剂,对被选择性 FA3R 拮抗剂 β-羟基丁酸酯 (BHB) 完全阻断的猪甲酚 (SALS) 提供保护作用。 | |||
T10359 |
AR antagonist 1
|
Androgen Receptor; Ligand for E3 Ligase; Ligands for Target Protein for PROTAC | Endocrinology/Hormones; PROTAC |
AR antagonist 1 是 AR 拮抗剂,能够与 E3 连接酶配体结合,与 VHL 蛋白结合亲和力较弱,用于 PROTACARD-266 合成。 | |||
T4236 |
AR-M 1000390 hydrochloride
ARM390 Hydrochloride,ARM-390 HCl |
Opioid Receptor | Endocrinology/Hormones; GPCR/G Protein; Neuroscience |
AR-M 1000390 hydrochloride (ARM-390 HCl) 是选择性 δ 阿片受体激动剂,EC50为 7.2±0.9 nM。 | |||
T6392 |
AR42
OSU-HDAC42,AR-42,(S)-(+)-N-羟基-4-(3-甲基-2-苯基丁酰氨基)苯甲酰胺,AR 42,HDAC-42 |
HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
AR42 (OSU-HDAC42) 是一种 HDAC 抑制剂(IC50: 30 nM)。 | |||
T60924 |
Verosudil
AR-12286 |
ROCK | Cell Cycle/Checkpoint; Cytoskeletal Signaling; Stem Cells |
Verosudil (AR-12286) 是一种高效的 Rho 激酶 (ROCK) 抑制剂,对 ROCK1 和 ROCK2 的 Ki 分别为 2 和 2 nM。AR-12286 可逆转类固醇诱导的小鼠眼内压,可通过增加眼房水通过小梁网流出来减缓眼压。 | |||
T10358 |
Netarsudil Dihydrochloride
AR-13324 Dihydrochloride |
ROCK | Cell Cycle/Checkpoint; Cytoskeletal Signaling; Stem Cells |
Netarsudil Dihydrochloride (AR-13324 Dihydrochloride) 是 Rho 相关蛋白激酶 (ROCK) 和去甲肾上腺素转运蛋白 (NET) 的抑制剂,可有效降低眼压 (IOP)。 | |||
T30110 |
AR 12456
AR12456,AR-12456 |
||
AR-12456 is a Trapidil derivative that prevents serum hyperlipidemia in guinea pigs. | |||
T39767 |
AR-C141990 hydrochloride
AR-C141990 hydrochloride |
||
AR-C141990 hydrochloride is a potent inhibitor of lactate transporters known as monocarboxylate transporters (MCTs). It has pK i values of 7.6 and 6.6 for MCT-1 and MCT-2, respectively. Additionally, this compound exhibits immunosuppressive properties and effectively inhibits the graft versus host response. | |||
T28881 |
Sulmazole
Vardax,AR-L 115BS,AR-L 115-BS |
PDE; Parasite; Adenosine Receptor | GPCR/G Protein; Metabolism; Microbiology/Virology; Neuroscience |
Sulmazole (AR-L 115-BS) 是一种小分子 cGMP-PDE抑制剂。Sulmazole 对 A1 腺苷受体具有竞争性抑制作用,可改善心脏指数,低肺毛细血管楔压,可用于研究心脏衰竭。 | |||
T10360 |
AR-A 2
AR-A 000002 |
Others | Others |
AR-A 2 is a selective 5-HT1B receptor antagonist, with a high affinity to guinea pig cortex 5HT1B/1D and recombinant guinea pig 5-HT1B receptors (Ki: 0.24 and 0.47 nM) and with 10-fold lower affinity to guinea pig 5-HT1D receptor (Ki: 5 nM). | |||
TQ0113 |
Iclaprim
艾拉普林,AR-100 |
Antibacterial; Antibiotic | Microbiology/Virology |
Iclaprim (AR-100) 是一种细菌二氢叶酸的选择性新型抑制剂, 可抑制金黄色葡萄球菌的生长, 其 MIC90值为 0.06 μg/mL。 | |||
T30111 |
AR 12465
AR-12465 |
||
AR 12465 is a trapidil derivative which may affect LDL receptor mediated uptake and degradation of 125 I-LDL by human skin fibroblasts (HSF) and human hepatic cells (HEP G2). | |||
T23752 |
AR-C141990
ARC-141990,AR C141990,ARC141990,ARC 141990 |
||
AR-C141990 is a lactate transporters inhibitor. | |||
T30120 |
AR-C126313
ARC126313,AR C126313 |
||
AR-C126313 is a thiouracil derivative. | |||
T6320 |
GDC-0879
GDC 0879,AR-00341677,GDC0879 |
Raf | MAPK |
GDC-0879 (AR-00341677) 是一种选择性B-Raf 抑制剂,IC50为 0.13 nM。 | |||
T3955 |
AR7
|
Retinoid Receptor | Metabolism |
AR7 是一种非典型的 RARA/RARα(视黄酸受体 α) 拮抗剂,能够特异性激活伴侣介导的自噬活性,对自噬无影响。 | |||
T30112 |
AR 17048
AR17048,AR-17048 |
||
AR-17048 is a potential anti-rheumatic drug. | |||
T0371 |
Gliquidone
AR-DF 26,格列喹酮,Glurenorm |
Potassium Channel | Membrane transporter/Ion channel |
Gliquidone (AR-DF 26) 是一种磺酰脲类的抗糖尿病药物,可用于2型糖尿病的研究。 | |||
T2466 |
Osu03012
Osu-03012,Osu 03012,AR-12 |
PDK | PI3K/Akt/mTOR signaling |
Osu03012 (AR-12) 是一种口服生物可利用的小分子塞来昔布衍生的磷酸肌醇依赖性激酶 1(PDK1) 抑制剂,具有潜在的抗肿瘤活性。 | |||
T0080 |
Trapidil
唑嘧胺,乐可安,Rocornal,Trapymine,Avantrin,Trapymin,AR-12008 |
PDGFR; PDE | Angiogenesis; Metabolism; Tyrosine Kinase/Adaptors |
Trapidil (Avantrin) 是一种抗血小板药物,是一种血管扩张剂,有特异性血小板衍生生长因子。 | |||
T30133 |
AR-L 100 BS
BRN 0842454,AR-L-100BS,AR-L100 BS |
||
AR-L 100 BS is a bioactive chemical with cardiovascular effects and blood pressure. | |||
T26657 |
AR-H067637
|
||
AR-H067637 is a rapid-binding, reversible and potent (inhibition constant K(i) = 2-4 nM), competitive inhibitor of thrombin, as well as of thrombin bound to fibrin (clot-bound thrombin) or to thrombomodulin. The total amount of free thrombin generated in | |||
T10052 |
AR-08
|
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
AR-08 是一种有效的 α2 肾上腺素能受体 (α2-adrenergic receptor) 激动剂,可用于研究多动症与注意力缺陷。 | |||
T30191L |
Atecegatran TFA
Atecegatran TFA(917904-13-3 Free base),AR-H067637 TFA |
Others | Others |
Atecegatran TFA 常被当作一种抗凝血剂,可用来治疗心血管疾病。 | |||
T26652 |
AR-C67085
PSB0413,PSB 0413,PSB-0413 |
||
AR-C67085 is a ADP receptor antagonist. | |||
T37822 | AR-C 141990 hydrochloride | ||
Monocarboxylate transporter (MCT1) inhibitor (pKi = 7.6. Exhibits approximately 10-fold selectivity for MCT1 over MCT2 and no significant activity against MCT3 or 4. Inhibits graft versus host response and prolongs cardiac graft survival in a rat model. Immunosuppressant. Also inhibits brain penetration of GHB analog HOCPCA. | |||
T69853 | AR-C117977 | ||
AR-C117977 is a potent MCT1 inhibitor, which can reduce vimmune responses both in vitro and in vivo, maintains long-term graft survival, and induces operational tolerance. | |||
T30114 |
AR-12463
AR12463 |
||
AR 12463 是一种曲匹地尔衍生物,可显着减少血清总胆固醇的增加。 | |||
T69613 | Ar-H047108 free base | ||
Ar-H047108 free base is an imidazopyridine potassium competitive acid blocker (P-CAB). This drug may be used to treat early stellate cell activation and veno-occlusive-disease (VOD)-like hepatotoxicity. | |||
T21059 |
Ticagrelor metabolite M5
Ticagrelor metabolite M5,,T437700,替格瑞洛杂质H,AR-C133913XX |
P2Y Receptor | GPCR/G Protein; Neuroscience |
Ticagrelor metabolite M5 (T437700) 是 Ticagrelor 的代谢物,是 P2Y12 受体的第一个可逆口服拮抗剂。与氯吡格雷相比,替格瑞洛对 ADP 受体具有更快和更一致的抑制作用。替格瑞洛用于治疗急性冠状动脉综合征(ACS)。 | |||
T30113 |
AR-102
UNII-54923Z352W |
||
AR-102 is a bio-active chemical. | |||
T0179 |
Ticagrelor
替格瑞洛,替卡格雷,AR-C 126532XX,AZD6140 |
P450; P2Y Receptor | GPCR/G Protein; Metabolism; Neuroscience |
Ticagrelor (AR-C 126532XX) (AZD6140) 是可逆的,可口服的 P2Y12受体拮抗剂,可抑制血小板聚集。 | |||
T21857 |
AR-R 17779 hydrochloride
|
||
AR-R17779 hydrochloride 是一种有效和选择性的 nAChR 完全激动剂,对α7和α4β2亚型的Ki 直分别为 92 和 16000 nM。AR-R17779 hydrochloride 可以改善大鼠的学习和记忆能力。AR-R17779 hydrochloride 也具有抗焦虑活性。AR-R17779 hydrochloride 可通过激活抗炎胆碱能(迷走神经)通路减轻炎症。 | |||
T22580 |
AR-C 102222
|
Others | Others |
AR-C 102222 is an iNOS inhibitor. | |||
T10361 | AR-C102222 hydrochloride | Others | Others |
AR-C102222 hydrochloride is a competitive, orally active, and highly selective inducible nitric oxide synthase (iNOS) inhibitor (IC50: 37 nM). It has antinociception and anti-inflammatory activities. | |||
T70956 | JNJ-pan-AR | ||
JNJ-pan-AR, a meylated analogue of JNJ-63576253, is a novel pan-AR antagonist with potent activity against wild-type and clinically relevant AR mutations including F877L. JNJ63576253, also known as TRC253, is a potent and orally active androgen receptor antagonist. TRC253 specifically binds to both wild-type and certain mutant forms of AR, thereby preventing androgen-induced receptor activation and facilitating the formation of inactive complexes that cannot translocate to the nucleus. | |||
T11804 |
β3-AR agonist 2
|
Others | Others |
β3-AR agonist 2 is a potent and selective agonist of β3-adrenergic receptor (β3-AR with an EC50 of 8 nM). | |||
T18596 |
PROTAC AR Degrader-4
|
Others | Others |
PROTAC AR Degrader-4 comprises a cIAP1 ligand binding group, a linker and an androgen receptor (AR) binding group. PROTAC AR Degrader-4 is an AR degrader. Degradation inducers based on cIAP1 are called specific and non-genetic IAP-dependent protein erasers (SNIPERs)[1]. | |||
T10523 |
β3-AR agonist 1
|
Others | Others |
β3-AR agonist 1 is a highly selective, and orally available agonist of β3-adrenergic receptor (EC50: 18 nM), being inactive to β1-, β2-, and α1A-AR (β1/β3, β2/β3, and α1A/β3>556-fold). | |||
T10358L |
AR-13324 M1 metabolite
|
Others | Others |
AR-13324 M1 metabolite is a hydrolysis metabolite of AR-13324 mesylate. | |||
T30134 |
AR-L 57 CL
|
||
AR-L 57 CL is a cardiotonic agent. | |||
T10357 |
AR-13324 analog mesylate
|
Others | Others |
AR-13324 analog mesylate is an inhibitor of Rho-kinase and a norepinephrine transporter and reduces intraocular pressure in normotensive monkey eyes. | |||
T30116 |
AR244555
AR-244555,AR 244555 |
||
AR244555 is a bioactive chemical. | |||
T126273 |
ar-Turmerol
|
||
ar-Turmerol 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T126273。 | |||
T26651 |
ARC-239
ARC239,AR C 239,AR C239,AR C-239 |
||
ARC-239 is an agonist of α2-adrenergic receptor. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1507 |
Clematichinenoside AR
|
TNF; Autophagy | Apoptosis; Autophagy |
Clematichinenoside AR 是从中药威灵仙中提取的一种天然产物,具有抗炎和免疫抑制特性,对 PI3K/Akt 信号通路和与胶原诱导的关节炎相关的 TNF-α± 具有抗关节炎作用。 | |||
TN7022 |
Cymen-ar-ol
|
Antibacterial | Microbiology/Virology |
Cymen-ar-ol 是一种广谱高效的杀菌剂,可接触黏膜。 | |||
T14317 |
ar-Turmerone
(+)-ar-Turmerone |
Others | Others |
ar-Turmerone ((+)-ar-Turmerone) is a major bioactive compound of the herb Curcuma longa with anti-tumorigenesis and anti-inflammatory activities[1][2][3]. ar-Turmerone ((+)-ar-Turmerone) exerts positive modulation on murine DCs, induces NSC proliferation. | |||
TN3436 |
ar-Curcumene
|
Others | Others |
ar-Curcumene has antiinflammatory activity, it could be used as antiinflammatory drugs in respiratory infections. ar-Curcumene is effective as oviposition deterrents against Anopheles stephensi, Aedes aegypti, and Culex quinquefasciatus, it can be conside | |||
TN5371 |
8-Hydroxy-ar-turmerone
|
||
8-Hydroxy-ar-turmerone may exhibit antitumor activity against breast cancer cells via cell death and cell cycle arrest. | |||
T27282 |
Erucin
AR 1G3839,AR-1G3839,CCRIS-9056,CCRIS9056,AR1G3839,CCRIS 9056 |
||
Erucin is a sulforaphane analog found in cruciferous vegtables. Erucin is a telomerase inhibitor. It induces phase II enzyme activity, suppresses cellular proliferation in hepatocellular carcinoma cells, prevents 6-OHDA-induced neurodegenration, and inhib | |||
T5711 |
Methylnissolin-3-O-glucoside
(6aR, 11 aR)-3-hydroxy-9,l0-diMethoxy pt,美迪紫檀苷,黄芪异黄烷苷,7,2'-二羟基-3',4'-二甲氧基异黄烷 |
Others | Others |
Methylnissolin-3-O-glucoside ((6aR, 11 aR)-3-hydroxy-9,l0-diMethoxy pt) 是一种类黄酮,从黄芪的根中获得,具有抗炎活性。 | |||
TN2037 |
Paeonilactone C
(3S,3AR,6S,7AR)-3-[(苯甲酰基氧基)甲基]四氢-6-羟基-6-甲基-2,5(3H,4H)-苯并呋喃二酮,芍药内苷 C |
Others | Others |
Paeonilactone C significantly protects primary cultures of rat cortical cells against H2O2-induced neurotoxicity. | |||
TN2035 |
Paeonilactone A
(3R,3AR,6S,7AR)-四氢-6-羟基-3,6-二甲基-2,5(3H,4H)-苯并呋喃二酮,芍药内苷A |
Others | Others |
Paeonilactone A是一种天然产物,属于芍药科芍药属,其产品编号为 TN2035,CAS号为 98751-79-2。Paeonilactone A可用作对照参考。 | |||
TN2388 |
Cleroindicin C
|
Others | Others |
Cleroindicin C is a natural product from plants | |||
T83554 |
(4R,4aS,5aS,6aR,6bS,7aR)-4-Hydroxy-3,6b-dimethyl-5-methylene-4,4a,5,5a,6,6a,7,7a-octahydrocyclopropa[2,3]indeno[5,6-b]furan-2(6bH)-one
|
||
'(4R,4aS,5aS,6aR,6bS,7aR)-4-Hydroxy-3,6b-dimethyl-5-methylene-4,4a,5,5a,6,6a,7,7a-octahydrocyclopropa[2,3]indeno[5,6-b]furan-2(6bH)-one' 是倍半萜类内酯化合物。 | |||
T67200 |
(1R,4aS,10aR)-methyl 7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxylate
|
||
(1R,4aS,10aR)-methyl 7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxylate 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 T67200,CAS号为 1235-74-1。 | |||
T83517 |
(Z)-(1R,3R,4R,4aS,8R,8aR)-3,4,8,8a-Tetramethyl-7-oxo-4-(2-(5-oxo-2,5-dihydrofuran-3-yl)ethyl)decahydronaphthalen-1-yl 2-methylbut-2-enoate
|
||
(Z)-(1R,3R,4R,4aS,8R,8aR)-3,4,8,8a-Tetramethyl-7-oxo-4-(2-(5-oxo-2,5-dihydrofuran-3-yl)ethyl)decahydronaphthalen-1-yl 2-methylbut-2-enoate (compound 7a) 是一种特定立体化学配置的二萜类化合物。 | |||
TCS1372 |
Atraric acid
|
Phosphatase; Androgen Receptor | Endocrinology/Hormones; Metabolism |
Atraric acid 衍生物作为一种新的化学先导结构,用于作为 AR 拮抗剂的新型治疗化合物,可用于预防或治疗前列腺疾病。它以剂量依赖性方式抑制 PTP1B 活性,IC50 值为 51.5 uM,表明阿特拉酸具有治疗糖尿病的潜力。 | |||
T5656 |
(±)-Norcantharidin
Endothall anhydride,去甲斑蝥素,Norcantharidin |
EGFR; c-Met/HGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
(±)-Norcantharidin (Endothall anhydride) 是一种人类结肠癌中 c-Met 和 EGFR 的双重抑制剂,可研究抗癌,具有抗血管生成活性。 | |||
T65128 |
Tartaric acid disodium dihydrate
Disodium L-(+)-Tartrate Dihydrate |
Phosphatase; Endogenous Metabolite | Metabolism |
Tartaric acid disodium dihydrate (Disodium L-(+)-Tartrate Dihydrate) 常用来制作分子生物学和细胞培养中的缓冲液,。Tartaric acid disodium dihydrate 是酸性磷酸酶抑制剂, 可增加秋水仙碱结合 tubulin1的概率。 | |||
T21665 |
DL-α-Hydroxyglutaric acid disodium salt
disodium 2-hydroxypentanedioate,DL-Α-羟基戊二酸二钠 |
Others | Others |
DL-α-Hydroxyglutaric acid disodium salt (disodium 2-hydroxypentanedioate) 是一种 α-羟基酸,由 (R) -5-oxy-2-tetrahydrofuran 羧酸水解形成,在人类神经代谢疾病 D-α-羟基戊二酸尿症中过量产生。 | |||
TN6780 |
Carvacrol methyl ether
Methyl carvacrol,Methyl carvacryl ether |
Antibacterial | Microbiology/Virology |
Carvacrol methyl ether 来源于植物挥发油,具有抗菌活性。 | |||
T5559 |
Carboxin
Carbathiin,Carboxine,Vitavax,Kisvax,萎锈灵 |
Others; Antibiotic; Antifungal | Microbiology/Virology; Others |
Carboxin (Kisvax)e 是一种内吸杀菌剂和种子保护剂。 | |||
T4814 |
(R)-5-Oxopyrrolidine-2-carboxylic acid
D-Pyroglutamic acid,(R)-(+)-2-Pyrrolidone-5-carboxylic acid,D-焦谷氨酸 |
Others; Endogenous Metabolite | Metabolism; Others |
(R)-5-Oxopyrrolidine-2-carboxylic acid (D-Pyroglutamic acid) 是内源性代谢产物的一种。 | |||
TQ0172 |
2''-O-Rhamnosylicariside II
|
Others | Others |
2''-O-Rhamnosylicariside II 是天然来源的黄酮类糖苷化合物,可能对改善绝经后骨质疏松有益处。 | |||
TQ0024 |
3-Hydroxyglutaric acid
|
Endogenous Metabolite | Metabolism |
3-Hydroxyglutaric acid 是一种戊二酸的衍生物。 | |||
T5625 |
Zearalenone
玉米,Mycotoxin F2,玉米烯酮,RAL,F2 toxin,Toxin F2 |
Others | Others |
Zearalenone (F2 toxin) 是真菌毒素,主要由食物和饲料中的 Fusarium 产生。它会引起幼龄母猪乳房发育早熟或其它雌激素效应。它在猪、牛、羊体内具有雌激素活性,急性毒性低。 | |||
T2826 |
Asaraldehyde
Asarylaldehyde,2,4,5-trimethoxy-Benzaldehyde,Asaronaldehyde,细辛醛 |
COX | Immunology/Inflammation; Neuroscience |
Asaraldehyde (2,4,5-trimethoxy-Benzaldehyde) 是COX-2抑制剂,能够明显降低环加氧酶 II (COX-2) 的活性(IC50:100 μg/mL)。 | |||
TJS1382 |
Taraxerone
蒲公英赛酮 |
Dehydrogenase | Metabolism |
Taraxerone 是分离自景天的天然产物。它可以增强乙醇脱氢酶和乙醛脱氢酶活性,EC50分别为 512.42 μM 和 500.16 μM。 | |||
T5781 |
taraxasteryl acetate
蒲公英甾醇醋酸酯,醋酸蒲公英酯 |
Antibacterial | Microbiology/Virology |
Taraxasteryl acetate 是分离自矢状疟原虫中,具有广谱的抗炎活性。它能够改善右旋糖酐、酵母聚糖及花生四烯酸诱导的大鼠后爪水肿。它可用于研究局部炎症。 | |||
T9510 |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine
DSPC,L-ALPHA-PHOSPHATIDYLCHOLINE, DISTEAROYL,1,2-Distearoyl-sn-glycero-3-PC,二硬脂酰磷脂酰胆碱 |
Others | Others |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine (L-ALPHA-PHOSPHATIDYLCHOLINE, DISTEAROYL) 是一种脂质纳米颗粒(LNP) 系统中的脂质成分,可用于合成脂质体。 | |||
TN2279 |
Totarol
(+)-Totarol,桃柁酚 |
Antibacterial; Antifection | Microbiology/Virology |
Totarol ((+)-Totarol) 对几种致病性革兰氏阳性细菌、结核分枝杆菌具有抗菌作用。 | |||
TN1918 |
Medicarpin
美迪紫檀素 |
Apoptosis; BCL; ROS; JNK | Apoptosis; Immunology/Inflammation; MAPK |
Medicarpin 是从紫花苜蓿中分离出的一种类黄酮。它通过调节 P-gp 介导的药物外流,诱导白血病 P388 细胞凋亡并克服多药耐药性。 | |||
T12581 |
Puerarin-4'-O-β-D-glucopyranoside
Puerarin4'-O-glucoside,葛根素-4'-Β-D-葡萄糖苷 |
Others | Others |
Puerarin-4'-O-β-D-glucopyranoside (Puerarin4'-O-glucoside) 是一种从葛根 (PLR) 中提取的异黄酮。它具有雌激素活性和抗 MCF-7 人乳腺癌细胞增殖作用。 | |||
TQ0183 |
Narciclasine
水仙环素,Lycoricidinol |
ROCK | Cell Cycle/Checkpoint; Cytoskeletal Signaling; Stem Cells |
Narciclasine (Lycoricidinol) 是一种植物生长调节剂。它通过调节Rho/Rho 激酶/LIM 激酶/cofilin 信号传导途径,大大增加GTP 酶RhoA 活性以及以RhoA 依赖性方式诱导肌动蛋白应力纤维形成。 | |||
TN1803 |
Isoscoparin
|
Antioxidant; TNF; NO Synthase; Fatty Acid Synthase | Apoptosis; Immunology/Inflammation; Metabolism; oxidation-reduction |
Isoscoparin 源自 Gentiana algida Pall,具有抗氧化和抗脂肪生成活性。Isoscoparin 可用于预防和治疗肥胖的研究。 | |||
TN1808 |
Isovitexin 2''-O-arabinoside
|
Others | Others |
Isovitexin 2''-O-arabinoside 是一种在紫花苜蓿植物中发现黄酮类化合物。 | |||
T37067 |
9-hydroxy Stearic Acid
|
HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
9-hydroxy Stearic Acid 是一种羟基脂肪酸,是9-PAHSA 的活性代谢物。9-hydroxy Stearic Acid 是由9-PAHSA 通过肝脏和胰腺的羧基酯脂肪酶形成的。9-hydroxy Stearic Acid (5 μM)抑制HT-29结肠癌细胞裂解物中组蛋白去乙酰化酶1 (HDAC1)的表达。3 .当浓度为100 μM.1时,可抑制HT-29细胞的增殖,并诱导细胞周期阻滞于G0/ g1期。 | |||
T8247 |
(+)-Aromadendrene
|
Anti-infection | Microbiology/Virology |
(+)-Aromadendrene 是一种天然产物,对革兰氏阳性菌和革兰氏阴性菌具有显着的抗菌活性。 | |||
TN2286 |
Tsugaric acid A
|
NO Synthase | Immunology/Inflammation |
Tsugaric acid A 能够显著抑制超氧阴离子的形成,还可以保护人类角质形成细胞,使其免受紫外线 B 诱导的损害。 | |||
T2O2731 |
L-Aspartic acid
L-天冬氨酸,L-天冬氨酸;L-天冬碱;L-酰胺天冬酸;L-天冬酰胺一水物,Aspatofort,Asparagic acid |
Others; Endogenous Metabolite | Metabolism; Others |
L-Aspartic acid (Aspatofort) 是一种氨基酸,是结肠特异性药物输送的前体药物。 | |||
TN1039 |
Tamarixetin
柽柳黄素,4'-O-Methyl Quercetin |
Endogenous Metabolite; Immunology/Inflammation related | Immunology/Inflammation; Metabolism |
Tamarixetin (4'-O-Methyl Quercetin) 是一种槲皮素的天然类黄酮衍生物,具有抗氧化、抗炎作用,能够防止心肌肥厚。 | |||
T3778 |
3'-Hydroxypuerarin
Pueraria glycoside,3'-hydroxy Puerarin,3'-羟基葛根素 |
Others | Others |
3'-Hydroxypuerarin (Pueraria glycoside) 是一种异黄酮,从 Pueraria lobata(Willd.) Ohwi 根部分离出来得到。它是抗氧化剂,具有显著的 ONOO(-),NO•,总 ROS 清除活性。 | |||
T7030 |
anemarsaponin B
知母皂苷B,知母皂苷 B |
p38 MAPK; NF-κB; MEK; COX; NO Synthase | Immunology/Inflammation; MAPK; Neuroscience; NF-κB |
Anemarsaponin B 是一种甾体皂苷,可降低iNOS 和COX-2的蛋白和 mRNA 水平,减少促炎细胞因子的表达和产生。它通过阻断 IκBα 的磷酸化来抑制NF-κB 的 p65 亚基的核转位,还抑制 MAP 激酶激酶 3/6 (MKK3/6) 和混合谱系激酶 3 的磷酸化。 | |||
T6S2023 |
Harpagoside
|
Others; COX; NO Synthase | Immunology/Inflammation; Neuroscience; Others |
Harpagoside 是从爪钩草中分离出来的一种天然产物,可抑制COX-1和COX-2活性,并抑制 NO 的产生。 | |||
T8249 |
Hexahydrofarnesyl acetone
植酮,Phytone |
Others; Antibacterial | Microbiology/Virology; Others |
Hexahydrofarnesyl acetone (Phytone) 是从Launaea mucronata 中分离得到的倍半萜,具有抗菌和抗炎活性,可研究缓解疼痛。 | |||
T2972 |
Rutaecarpine
Rutacarpine,吴茱萸次碱,Rhetine,Rutecarpine |
COX | Immunology/Inflammation; Neuroscience |
Rutaecarpine (Rhetine) 是从槐木中提取的一种生物碱,是 COX-2的抑制剂,IC50值为0.28 μM。 | |||
T2729 |
Scoparone
滨蒿内酯,Escoparone,Scoparon,Aesculetin dimethyl ether,6,7-dimethoxycoumarin,6,7-Dimethylesculetin |
Others | Others |
Scoparone (Aesculetin dimethyl ether) 是分离自毛蒿中,具有抗凝血,抗血管舒张作用和抗炎活性。 | |||
T4911 |
α-Arbutin
4-hydroxyphenyl-D-lucopyranoside,alpha-Arbutoside,α-熊果苷,alpha-Arbutin |
Tyrosinase | Proteases/Proteasome |
α-Arbutin (4-hydroxyphenyl-D-lucopyranoside) 是一种流行的、有效的皮肤增白剂,也是一种酪氨酸酶 (tyrosinase) 抑制剂。 | |||
TQ0197 |
Acenocoumarol
醋硝香豆素,新抗凝 |
||
Acenocoumarol 是一种抗凝血剂,与 Vitamin K 拮抗剂的功能相似。 | |||
T5041 |
Faropenem sodium
法罗培南,法罗培南钠 |
Antibacterial; Antibiotic | Microbiology/Virology |
Faropenem sodium 是一种口服生物可利用的青霉烯类抗生素,能有效杀灭结核分枝杆菌,治疗结核病和社区获得性肺炎。 | |||
T19564 |
Stearoylcarnitine
Stearoyl-L-carnitine |
Endogenous Metabolite | Metabolism |
Stearoylcarnitine (Stearoyl-L-carnitine) 是一种脂肪酯脂质分子,是一种人内源代谢产物,可作为早发型子痫前期和晚发性子痫前期的生物标志物。 | |||
T3S1944 |
Darutoside
Darutin,豯莶苷 |
Others | Others |
Darutoside (Darutin) 是一种二萜化合物,提取自Siegesbeckia 中。 | |||
T4S1962 |
beta-Asarone
β-细辛脑,(Z)-1,2,4-三甲氧基-5-丙烯基苯;顺式细辛脑,Cis-Isoasarone,Cis-Asarone,Cis-Isoelemicin |
NF-κB; JNK | MAPK; NF-κB |
beta-Asarone (Cis-Isoelemicin) 是一种石菖蒲中的主要成分,具有免疫抑制、促进安定、中枢神经系统抑制、降温等功能。它可透过血脑屏障,能够预防帕金森病。 | |||
------------------------ 更多 ------------------------ |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPK-00870 |
AREG Protein, Mouse, Recombinant (hFc)
AR,MGC13647,CRDGF,AREG,Amphiregulin,SDGF,<... |
Mouse | HEK293 Cells |
Amphiregulin (AREG) is a ligand of the epidermal growth factor receptor (EGFR), a widely expressed transmembrane tyrosine kinase. AREG is synthesized as a membrane-anchored precursor protein that can engage in juxtacrine signaling on adjacent cells. Alternatively, after proteolytic processing by cell membrane proteases, mainly TACE/ADAM17, AREG is secreted and behaves as an autocrine or paracrine factor. | |||
TMPK-00820 |
AREG Protein, Human, Recombinant (hFc)
SDGF,AR,MGC13647,AREGB,CRDGF,Amphiregulin,... |
Human | HEK293 Cells |
Amphiregulin (AREG) is a member of the epidermal growth factor (EGF) family and is expressed in a plethora of cancers. Tumour growth and metastasis were decreased by AREG silencing in an orthotopic model of pancreatic cancer. AREG may play a critical role in cell migration, invasion, and EMT by activating the EGFR/ERK/NF‑κB signalling pathway in pancreatic cancer cells. | |||
TMPJ-00859 |
AREG Protein, Human, Recombinant
AR,CRDGF,Amphiregulin,Colorectum Cell-Derived Growt... |
Human | E. coli |
Amphiregulin (AREG) is a single-pass membrane protein with 252 amino acids. AREG belongs to the amphiregulin family, which contains 1 EGF-like domain. AREG is expressed in a variety of tissues including ovary, placenta, lung, kidney, stomach, colon, and breast. It is related to Epidermal Growth Factor (EGF) and Transforming Growth Factor Alpha (TGF-alpha). As an EGF-related growth factor, AREG interacts with the EGF/TGF-alpha receptor to promote the growth of normal epithelial cells and inhibits... | |||
TMPH-01294 |
EDNRA Protein, Human, Recombinant (His)
ET-A,Endothelin-1 receptor,hET-AR,ETA-R,ETRA,EDNRA,... |
Human | P. pastoris (Yeast) |
Receptor for endothelin-1. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. The rank order of binding affinities for ET-A is: ET1 > ET2 >> ET3. | |||
TMPH-00287 |
Adrenodoxin reductase Protein, Bovine, Recombinant (E. coli, His)
Ferredoxin--NADP(+) reductase,ADXR,NADPH:adrenodoxin oxidore... |
Bovine | E. coli |
Serves as the first electron transfer protein in all the mitochondrial P450 systems including cholesterol side chain cleavage in all steroidogenic tissues, steroid 11-beta hydroxylation in the adrenal cortex, 25-OH-vitamin D3-24 hydroxylation in the kidney, and sterol C-27 hydroxylation in the liver. Adrenodoxin reductase Protein, Bovine, Recombinant (E. coli, His) is expressed in E. coli expression system with N-10xHis tag. The predicted molecular weight is 55.8 kDa and the accession number is ... | |||
TMPH-00932 |
Androgen receptor Protein, Human, Recombinant (His & Myc & SUMO)
Nuclear receptor subfamily 3 group C member 4,A... |
Human | E. coli |
Androgen receptor Protein, Human, Recombinant (His & Myc & SUMO) is expressed in E. coli. | |||
TMPH-00288 |
Adrenodoxin reductase Protein, Bovine, Recombinant (His)
Ferredoxin reductase,Adrenodoxin reductase,Ferredoxin--NADP(... |
Bovine | P. pastoris (Yeast) |
Serves as the first electron transfer protein in all the mitochondrial P450 systems including cholesterol side chain cleavage in all steroidogenic tissues, steroid 11-beta hydroxylation in the adrenal cortex, 25-OH-vitamin D3-24 hydroxylation in the kidney, and sterol C-27 hydroxylation in the liver. Adrenodoxin reductase Protein, Bovine, Recombinant (His) is expressed in yeast with N-10xHis tag. The predicted molecular weight is 52.8 kDa and the accession number is P08165. | |||
TMPY-02438 |
AKR1B1 Protein, Human, Recombinant (His)
ALDR1,AR,ADR,aldo-keto reductase family 1, member B... |
Human | E. coli |
Aldose reductase (AKR1B1) belongs to the aldo/keto reductase superfamily. AKR1B1 is a NADPH-dependent aldo-keto reductase best known as the rate-limiting enzyme of the polyol pathway. Expression of AKR1B1 was the highest in lens and retina. It is the first enzyme in the polyol pathway through which glucose is converted to sorbitol which is important for the function of various organs in the body, and has been implicated in the etiology of diabetic complications. AKR1B1 is quite abundant in the c... | |||
TMPK-00861 |
A2AR Protein-VLP, Human, Recombinant
RDC8,Adenosine A2a R,ADORA2,ADORA 2,ADORA2A,A2aR |
Human | HEK293 Cells |
Adenosine is a neuromodulator in the adult central nervous system. Membrane-bound receptors for adenosine have been identified and cDNAs for A1, A2a, A2b, and A3 adenosine receptor subtypes have been cloned recently.Expression of A2a adenosine receptor mRNA in cranial ganglia, carotid body, and intermediate lobe of the pituitary gland similarly suggests novel sites of adenosine action during development and in the adult. | |||
TMPH-00892 |
A1AR Protein, Human, Recombinant (His)
Adenosine receptor A1,ADORA1 |
Human | E. coli |
Receptor for adenosine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase. A1AR Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-10xHis tag. The predicted molecular weight is 39.3 kDa and the accession number is P30542. | |||
TMPH-01022 |
C5AR1 Protein-VLP, Human, Recombinant (His)
C5a anaphylatoxin chemotactic receptor 1,CD88,C5a anaphylato... |
Human | HEK293 Cells |
Receptor for the chemotactic and inflammatory peptide anaphylatoxin C5a. The ligand interacts with at least two sites on the receptor: a high-affinity site on the extracellular N-terminus, and a second site in the transmembrane region which activates downstream signaling events. Receptor activation stimulates chemotaxis, granule enzyme release, intracellular calcium release and superoxide anion production. C5AR1 Protein-VLP, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-... | |||
TMPH-01023 |
C5AR1 Protein, Human, Recombinant (Cell-Free, His)
C5a anaphylatoxin chemotactic receptor 1,C5R1,C5a-R,C5a anap... |
Human | E. coli |
Receptor for the chemotactic and inflammatory peptide anaphylatoxin C5a. The ligand interacts with at least two sites on the receptor: a high-affinity site on the extracellular N-terminus, and a second site in the transmembrane region which activates downstream signaling events. Receptor activation stimulates chemotaxis, granule enzyme release, intracellular calcium release and superoxide anion production. C5AR1 Protein, Human, Recombinant (Cell-Free, His) is expressed in E. coli expression syst... | |||
TMPH-03765 |
Virus-Like Particles (VLPs) isotype control
|
HEK293 | |
Virus-Like Particles (VLPs) isotype control can be used as the control of VLP expressed proteins. | |||
TMPY-01776 |
Carboxylesterase 2/CES2 Protein, Human, Recombinant (His)
carboxylesterase 2,CES2A1,CE-2,PCE-2,iCE |
Human | HEK293 Cells |
Carboxylesterase 2/CES2 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 60.4 kDa and the accession number is O00748-1. | |||
TMPY-02130 |
Argonaute-2 Protein, Mouse, Recombinant (His)
mKIAA4215,1110029L17Rik,2310051F07Rik,Ago2,argonaut... |
Mouse | Baculovirus Insect Cells |
Argonaute-2 Protein, Mouse, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 99 kDa and the accession number is Q8CJG0. | |||
TMPY-00144 |
Epstein-Barr virus (Herpesvirus 4) EBV Glycoprotein gp350/EBV GP350 Protein (His)
BLLF1,gp22 |
EBV | Baculovirus Insect Cells |
Epstein-Barr virus (Herpesvirus 4) EBV Glycoprotein gp350/EBV GP350 Protein (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 53.7 kDa and the accession number is A0A0B6VN60. | |||
TMPY-00411 |
Influenza A H5N1 (A/bar-headed goose/Qinghai/1A/2005) Hemagglutinin/HA Protein (His)
Harvey rat sarcoma viral oncogene homolog |
H5N1 | Baculovirus Insect Cells |
Influenza A H5N1 (A/bar-headed goose/Qinghai/1A/2005) Hemagglutinin/HA Protein (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 59.6 kDa and the accession number is Q195D4. | |||
TMPY-01188 |
PARP Protein, Human, Recombinant (His)
ADPRT1,ADPRT,pADPRT-1,PPOL,ARTD1,PARP-1,po... |
Human | Baculovirus Insect Cells |
PARP Protein, Human, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 114.5 kDa and the accession number is A0A024R3T8. | |||
TMPY-02575 |
PPAR gamma/PPARG Protein, Human, Recombinant (His & GST)
CIMT1,PPARγ,GLM1,PPARgamma,PPARG1... |
Human | Baculovirus Insect Cells |
Peroxisome proliferator-activated receptor gamma (PPARG), a nuclear hormone receptor, plays a critical role in the lipid and glucose homeostasis, adipocyte differentiation, as well as intracellular insulin-signaling events. The peroxisome proliferator-activated receptor gamma (PPARgamma) regulates osteoblast and osteoclast differentiation, and is the molecular target of thiazolidinediones (TZDs), insulin sensitizers that enhance glucose utilization and adipocyte differentiation. Peroxisome proli... | |||
TMPY-00694 |
Carbonic Anhydrase 12 Protein, Human, Recombinant (His)
HsT18816,FLJ20151,carbonic anhydrase XII,CA12,CAXII |
Human | HEK293 Cells |
Carbonic Anhydrase 12 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 31.6 kDa and the accession number is O43570-1. | |||
TMPY-02141 |
uPAR/PLAUR Protein, Human, Recombinant (His)
UPAR,CD87,plasminogen activator, urokinase receptor... |
Human | HEK293 Cells |
uPAR/PLAUR Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 32.8 kDa and the accession number is Q03405-1. | |||
TMPY-04799 |
IFNAR2 Protein, Human, Recombinant (His), Biotinylated
IFN-R,interferon (α, β and Ω) receptor 2,IFNABR,interferon (... |
Human | HEK293 Cells |
IFNAR2 Protein, Human, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 26.2 kDa and the accession number is P48551-1. | |||
TMPY-01257 |
uPAR/PLAUR Protein, Mouse, Recombinant (His)
uPAR,Cd87,u-PAR,plasminogen activator, uro... |
Mouse | HEK293 Cells |
uPAR/PLAUR Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 31.4 kDa and the accession number is P35456-1. | |||
TMPY-02617 |
Influenza A H2N2 (A/Ann Arbor/6/1960) Nucleoprotein/NP Protein (His)
NP Protein |
H2N2 | Baculovirus Insect Cells |
Influenza A H2N2 (A/Ann Arbor/6/1960) Nucleoprotein/NP Protein (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 57 kDa and the accession number is P21433-1. | |||
TMPY-04180 |
PfLDH Protein, P. falciparum, Recombinant (His)
PfLDH,L-lactate dehydrogenase |
P. falciparum | E. coli |
Plasmodium falciparum lactate dehydrogenase (PfLDH) is a key enzyme for energy generation of malarial parasites and is considered to be a potential antimalarial target. The ability of PfLDH- or PfIDEh-based immuno-PCR assays to detect <1 parasite/microL suggests that improvements of bound antibody sensor technology may greatly increase the sensitivity of malaria rapid diagnostic tests. The PfLDH test could be used to detect failures and, therefore, to assess anti-malarial efficacy. | |||
TMPY-01186 |
Argonaute-2 Protein, Human, Recombinant (His)
EIF2C2,argonaute RISC catalytic component 2,Ar<... |
Human | Baculovirus Insect Cells |
Argonaute-2 Protein, Human, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 99 kDa and the accession number is Q9UKV8. | |||
TMPY-06071 |
SARS-CoV-2 RNA-dependent RNA polymerase/RDRP Protein (His)
|
SARS-CoV-2 | Baculovirus Insect Cells |
SARS-CoV-2 RNA-dependent RNA polymerase/RDRP Protein (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 108.3 kDa and the accession number is YP_009725307.1. | |||
TMPK-00265 |
SARS-COV-2 Nucleocapsid Protein (His & Avi), Biotinylated
Nucleocapsid,NC,NP |
SARS-CoV-2 | E. coli |
Nucleocapsid protein (N) is the major viral structural component; its main function is to protect and encapsidate the viral RNA forming viral RNP complex. It is encoded by the S segment vRNA and is abundantly expressed in the cytoplasm of infected cells. SARS-COV-2 Nucleocapsid Protein (His & Avi), Biotinylated is expressed in E. coli expression system with N-His-Avi tag. The predicted molecular weight is 48.9 kDa and the accession number is P0DTC9. | |||
TMPY-00690 |
Carbonic Anhydrase 9 Protein, Human, Recombinant (His)
Carbonic Anhydrase IX,MN,CAIX |
Human | HEK293 Cells |
Carbonic Anhydrase 9 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 42.5 kDa and the accession number is A0A0S2Z3D0. | |||
TMPY-05679 |
SARS-CoV-2 Spike RBD Protein (hFc)
|
SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (hFc) is expressed in HEK293 mammalian cells. The predicted molecular weight is 51.8 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-02121 |
CXADR/CAR Protein, Human, Recombinant (His)
coxsackie virus and adenovirus receptor,CAR,CXADR,C... |
Human | HEK293 Cells |
CXADR/CAR Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 25.6 kDa and the accession number is P78310-1. | |||
TMPY-02647 |
IFNAR1 Protein, Human, Recombinant (His)
interferon (alpha, beta and omega) receptor 1,IFN-α-REC,IFRC... |
Human | HEK293 Cells |
IFNAR1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 48.6 kDa and the accession number is P17181-1. | |||
TMPY-01735 |
Carbonic Anhydrase 2 Protein, Human, Recombinant (His)
HEL-S-282,CA-II,HEL-76,CAII,carbonic anhydrase II,C... |
Human | E. coli |
Carbonic Anhydrase 2 Protein, Human, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 30 kDa and the accession number is P00918. | |||
TMPY-01081 |
SR-BI/SCARB1 Protein, Human, Recombinant (His)
SR-BI,SRB1,HDLQTL6,CD36L1,CLA-1,scavenger receptor class B, ... |
Human | HEK293 Cells |
SR-BI/SCARB1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 48 kDa and the accession number is A0A024RBS4. | |||
TMPY-00689 |
Carbonic Anhydrase 9 Protein, Human, Recombinant (hFc)
CAIX,Carbonic Anhydrase IX,MN |
Human | HEK293 Cells |
Carbonic Anhydrase 9 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 67.7 kDa and the accession number is A0A0S2Z3D0. | |||
TMPY-01761 |
Carbonic Anhydrase 3 Protein, Human, Recombinant (His)
carbonic anhydrase III,CAIII,Car3 |
Human | E. coli |
Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes first discovered in 1933 that catalyze the reversible hydration of carbon dioxide. CAs participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. Carbonic anhydrases (CAs) form a family of enzymes that catalyze the rapid conversion of carbon dioxide and water to bicarbonate an... | |||
TMPY-02003 |
FH/Fumarate Hydratase Protein, Human, Recombinant (His)
fumarate hydratase,MCL,LRCC,MCUL1,FMRD,HLRCC |
Human | E. coli |
Fumarate Hydratase (FH) is an enzymatic component of the tricarboxylic acid (TCA) cycle, or Krebs cycle, and catalyzes the formation of L-malate from fumarate. It exists in both a cytosolic form and an N-terminal extended form, differing only in the translation start site used. The N-terminal extended form is targeted to the mitochondrion, where the removal of the extension generates the same form as in the cytoplasm. Fumarate Hydratase is similar to some thermostable class II fumarases and func... | |||
TMPY-02176 |
Harmonin/USH1C Protein, Human, Recombinant (His)
PDZD7C,PDZ-73,PDZ73,DFNB18A,PDZ-73/NY-CO-38,DFNB18,NY-CO-37,... |
Human | E. coli |
Harmonin, also known as Antigen NY-CO-38 / NY-CO-37, Autoimmune enteropathy-related antigen AIE-75, Protein PDZ-73, Renal carcinoma antigen NY-REN-3, Usher syndrome type-1C protein and USH1C, is a protein that is expressed in small intestine, colon, kidney, eye and weakly in pancreas. USH1C is expressed also in vestibule of the inner ear. USH1C contains 3 PDZ (DHR) domains. USH1C may be involved in protein-protein interaction. Defects in USH1C are the cause of Usher syndrome type 1C (USH1C), als... | |||
TMPY-03060 |
Parvin alpha/PARVA Protein, Human, Recombinant (GST)
parvin, alpha,parvin, α,MXRA2,CH-ILKBP,P |
Human | E. coli |
Actopaxin, also known as alpha-parvin, belongs to the parvin family. It is widely expressed, with highest levels in heart, skeletal muscle, kidney and liver. Actopaxin contains 2 CH (calponin-homology) domains and probably plays a role in the regulation of cell adhesion and cytoskeleton organization. It interacts with integrin-linked protein kinase and probably with actin and the LD1 and LD4 motifs of PXN. Actopaxin binds directly to both F-actin and paxillin LD1 and LD4 motifs. Actopaxin also e... | |||
TMPY-01351 |
Carbonic Anhydrase 10 Protein, Human, Recombinant (His)
carbonic anhydrase X,CA-RPX,CARPX,CA10,HUC... |
Human | HEK293 Cells |
Carbonic Anhydrase 10 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 33 kDa and the accession number is A0A384MTY8. | |||
TMPY-06722 |
SARS-CoV-2 (XBB.1.5) Spike S1 Protein (His)
|
SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 (XBB.1.5) Spike S1 Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 76.17 kDa and the accession number is YP_009724390.1. | |||
TMPH-00787 |
BtuD Protein, Halobacterium salinarum, Recombinant
Vitamin B12-transporting ATPase,Cobalamin import ATP-binding... |
Halobacterium salinarum | E. coli |
Required for corrinoid utilization. Probably part of the ABC transporter complex BtuCDF involved in cobalamin (vitamin B12) import. Probably responsible for energy coupling to the transport system. | |||
TMPK-00439 |
SARS-COV-2 Spike RBD Protein (His & Avi), Biotinylated
S protein RBD,S glycoprotein RBD,Spike protein RBD |
SARS-CoV-2 | HEK293 Cells |
The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. SARS-COV-2 Spike RBD Protein (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 27 kDa and the accession nu... | |||
TMPK-00410 |
AXL Protein (Primary Amine Labeling), Human, Recombinant (hFc), Biotinylated
ARK,EC 2.7.10.1,EC 2.7.10,Axl,JTK11,AXL oncogene,UF... |
Human | HEK293 Cells |
Axl, a member of the TAM (Tyro3, Axl, Mer) family, and its inhibitors can specifically break the kinase signaling nodes, allowing advanced patients to regain drug sensitivity with improved therapeutic efficacy. Overexpression and activation of Axl receptor tyrosine kinase have been widely accepted to promote cell proliferation, chemotherapy resistance, invasion, and metastasis in several human cancers, such as lung, breast, and pancreatic cancers. AXL Protein (Primary Amine Labeling), Human, Rec... | |||
TMPK-00005 |
CD24 Protein (Primary Amine Labeling), Human, Recombinant (hFc), Biotinylated
CD24A,FLJ22950,CD24 molecule,CD 24,FLJ43543,MGC75043 |
Human | HEK293 Cells |
CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers. CD24 Protein (Primary Amine Labeling), Human, Recombinant (hFc), Biotinylated is expressed in HEK293 mammalian cells with C-hFc tag. The predicted molecular weight is 29.9 kDa and ... | |||
TMPK-00267 |
SARS-COV-2 Nucleocapsid Protein NTD Domain (His & Avi), Biotinylated
NP,Nucleocapsid,NC |
SARS-CoV-2 | E. coli |
Nucleocapsid protein (N) is the major viral structural component; its main function is to protect and encapsidate the viral RNA forming viral RNP complex. It is encoded by the S segment vRNA and is abundantly expressed in the cytoplasm of infected cells. SARS-COV-2 Nucleocapsid Protein NTD Domain (His & Avi), Biotinylated is expressed in E. coli expression system with N-His-Avi tag. The predicted molecular weight is 16.3 kDa and the accession number is P0DTC9. | |||
TMPK-00262 |
SARS-COV-2 Nucleocapsid Protein NTD Domain (His & Avi)
NC,Nucleocapsid,NP |
SARS-CoV-2 | E. coli |
Nucleocapsid protein (N) is the major viral structural component; its main function is to protect and encapsidate the viral RNA forming viral RNP complex. It is encoded by the S segment vRNA and is abundantly expressed in the cytoplasm of infected cells. SARS-COV-2 Nucleocapsid Protein NTD Domain (His & Avi) is expressed in E. coli expression system with N-His-Avi tag. The predicted molecular weight is 16.3 kDa and the accession number is P0DTC9. | |||
TMPK-00227 |
uPAR/PLAUR Protein, Human, Recombinant (His & Avi), Biotinylated
CD87,PLAUR,U-PAR,MO3,uPAR |
Human | HEK293 Cells |
The receptor (u-PAR) for urokinase plasminogen activator (u-PA) is a three-domain protein, GPI-anchored to the cell surface, which focuses the enzymatic activity of u-PA, and allows the cell surface activation of plasminogen.Regulation of the activity of u-PA is also mediated by u-PAR. uPAR/PLAUR Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 34.36 kDa and the accession number is Q03405-1. | |||
TMPK-00912 |
SARS Spike RBD Protein (His & Avi), Biotinylated
S glycoprotein RBD,S protein RBD,Spike protein RBD |
SARS | HEK293 Cells |
The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. SARS Spike RBD Protein (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 27.9 kDa and the accession number... | |||
TMPK-00937 |
CKAP4 Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated
p63,CLIMP-63,ERGIC-63 |
Human | E. coli |
Cytoskeleton-associated protein 4 (CKAP4) is located in the rough endoplasmic reticulum (ER) and plays an important role in stabilizing the structure of ER. Meanwhile, CKAP4 is also found to act as an activated receptor at the cell surface. CKAP4 Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated is expressed in E. coli expression system with N-His tag. The predicted molecular weight is 53.66 kDa and the accession number is Q07065. | |||
------------------------ 更多 ------------------------ |